• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments Product Image

World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments

  • Published: October 2003
  • Region: Global
  • Frost & Sullivan



Establishing Credibility Ensures Success for Drug Discovery Contract Research Companies

Industry participants that provide the specialized knowledge and superior standard of research required for drug discovery will attract global sponsorship and gain a head start in the current competitive scenario. This credibility can be built with an impressive history of previous contract research work completed, with emphasis on the type of work, its quality, and the sponsor involved. Superior domain expertise, technical skill sets of people, and high quality manpower and infrastructure will go a long way toward establishing relationships with companies that are looking to partner with the best in the field. Since global drug discovery majors prefer platform technologies, companies with validated and robust technology platforms will enjoy sustained growth.

This new research service provides a comprehensive analysis of the global drug discovery contract research opportunities in ten leading market segments. Based on the expected impact of identified drivers, restraints, challenges, and trends, market analysis is provided for each segment. This study also provides an overview READ MORE >

1 EXECUTIVE SUMMARY
  Executive Summary
      1. Executive Summary
  2 OVERVIEW
  Overview
      1. Introduction
      2. Scope of Report
  Challenges
      1. Challenges
      2. Establishing Credibility
      3. Developing Strategic Fit between Outsourcers and CRO
      4. Moving up the Value Chain
  Drivers
      1. Market Drivers
      2. Global R&D Productivity
      3. Cost Advantages Leading to Growth in Outsourcing
      4. Increase in Time and Labor Intensive R&D Processes
  Restraints
      1. Market Restraints
      2. Lack of Strong IPR Protection
      3. Lack of Domain Expertise Limiting CR Opportunities
      4. Unavailability of World-Class Infrastructure and Manpower
  3 TOP TEN SEGMENTS AND TOP OUTSOURCERS OF DRUG DISCOVERY
  Oncology
      1. Overview
      2. AMGEN
      3. Pfizer
      4. GlaxoSmithKline
      5. Hoffmann-La Roche
      6. Johnson & Johnson
  Central Nervous System (CNS)
      1. Overview
      2. Amgen
      3. GlaxoSmithKline
      4. Taisho Pharmaceuticals
      5. Eli Lilly
      6. Novartis AG
  Autoimmune/Inflammation
      1. Overview
      2. Eli Lilly
      3. Suntory Pharmaceutical
      4. Procter & Gamble
      5. Encysive Pharmaceuticals
      6. Novartis AG
  Cardiovascular (CVS)
      1. Overview
      2. Schering-Plough Corporation
      3. Bayer AG
      4. GlaxoSmithKline
      5. Eli Lilly
      6. Chiron Corporation
  Infectious Diseases
      1. Overview
      2. Pfizer
      3. Hoffmann-La Roche
      4. GlaxoSmithKline
      5. Abbott Laboratories
      6. Immuno-Designed Molecules SA
  Broad-based Screening
      1. Overview
      2. Pfizer
      3. Procter & Gamble
      4. Eli Lilly
      5. Merck & Co
      6. Novartis AG
  Chemistry
      1. Overview
      2. Novartis AG
      3. Aventis Pharmaceuticals
      4. Eli Lilly
      5. Bayer AG
      6. Pfizer
  Genomic Targets
      1. Overview
      2. Hoffmann-La Roche
      3. BASF AG
      4. The Dow Chemical Company
      5. E.I. du Pont de Nemours and Company
      6. Bayer AG
  Metabolism
      1. Overview
      2. Genzyme Corporation
      3. Johnson & Johnson
      4. Schering-Plough Corporation
      5. Pfizer
      6. Kirin Brewery
  Gene Therapy
      1. Overview
      2. Aventis Pharmaceuticals
      3. Japan Tobacco Inc
      4. Schering AG
      5. Celltech Group
      6. Transkaryotic Therapies Inc
  4 MARKET OPPORTUNITY ANALYSIS
  Analysis
      1. Introduction
      2. Segment-wise Analysis
  Market Trends
      1. Trends
  5 SUSTAINABLE GROWTH STRATEGIES
  Entry Strategies
      1. Selecting the Right Segment
      2. Develop Innovative Technology Platforms
      3. Selecting the Right Partner
  Growth Strategies
      1. Focus on Strong Outsourcers
      2. Focus on Therapeutic Areas Witnessing Cutting-Edge Research
      3. Build a Strong Reputation
  6 DATABASE OF KEY INDUSTRY PARTICIPANTS
  Database of Key Outsourcers
      1. List of Companies
  

List Of Figures

Chapter 2

Overview
Drug Discovery Contract Research Markets: Impact of Industry Challenges (Global), 2002-2010
Drug Discovery Contract Research Markets: Market Drivers Ranked in Order of Impact (Global), 2002-2010
Drug Discovery Contract Research Markets: Market Restraints Ranked in Order of Impact (Global), 2002-2010

Chapter 3

Top Ten Segments and Top Outsourcers of Drug Discovery
Drug Discovery Contract Research Markets: Oncology Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Oncology Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Amgen Alliance Segment-wise Payouts (Global), 1990-2002
Drug Discovery Contract Research Markets: Amgen Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Segment-wise Payouts (Global), 1986-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Oncology Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Roche Oncology Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Johnson & Johnson Oncology Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: Johnson & Johnson Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Johnson & Johnson Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: CNS Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: CNS Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Amgen Alliance Segment-wise Payouts (Global), 1990-2002
Drug Discovery Contract Research Markets: Amgen Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline's CNS Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Taisho Pharmaceuticals Alliance Segment-wise Payouts (Global), 1999-2002
Drug Discovery Contract Research Markets: Taisho Pharmaceuticals Alliance Payouts (Global), 1999-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Novartis Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: Novartis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Autoimmune/Inflammation Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Autoimmune/Inflammation Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Suntory Pharmaceutical Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: P&G Alliance Segment-wise Payouts (Global), 1991-2002
Drug Discovery Contract Research Markets: P&G Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Encysive Pharmaceuticals (formerly Texas Biotech) Alliance Payouts (Global), 2000-2002
Drug Discovery Contract Research Markets: Novartis Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: Novartis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: CVS Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: CVS Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Schering-Plough Alliance Segment-wise Payouts (Global), 1988-2002
Drug Discovery Contract Research Markets: Schering-Plough Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Bayer AG Alliance Segment-wise Payouts (Global), 1993-2002
Drug Discovery Contract Research Markets: Bayer AG Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline CVS Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Chiron Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Chiron Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Infection Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Infection Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Segment-wise Payouts (Global), 1986-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Roche Infection Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Infection Product Pipeline (Global), 2003
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: GlaxoSmithKline Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Abbott Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Abbott Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Immuno-Designed Alliance Payouts (Global), 2000-2002
Drug Discovery Contract Research Markets: Broad-based Screening Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Broad-based Screening Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Segment-wise Payouts (Global), 1986-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: P&G Alliance Segment-wise Payouts (Global), 1991-2002
Drug Discovery Contract Research Markets: P&G Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Merck Alliance Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Merck Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Novartis Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: Novartis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Chemistry Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Chemistry Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Novartis Alliance Segment-wise Payouts (Global), 1987-2002
Drug Discovery Contract Research Markets: Novartis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Aventis Alliance Segment-wise Payouts (Global), 1991-2002
Drug Discovery Contract Research Markets: Aventis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Eli Lilly Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Bayer AG Alliance Segment-wise Payouts (Global), 1993-2002
Drug Discovery Contract Research Markets: Bayer AG Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Segment-wise Payouts (Global), 1986-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Genomic Targets Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Genomic Targets Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Hoffmann-La Roche Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: BASF Alliance Segment-wise Payouts (Global), 1996-2002
Drug Discovery Contract Research Markets: BASF Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Dow Chemical Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Dow Chemical Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: DuPont Alliance Segment-wise Payouts (Global), 1996-2002
Drug Discovery Contract Research Markets: DuPont Alliance Payouts (Global), 1998-2001
Drug Discovery Contract Research Markets: Bayer AG Alliance Segment-wise Payouts (Global), 1993-2002
Drug Discovery Contract Research Markets: Bayer AG Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Metabolic Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Metabolic Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Genzyme Alliance Segments (Global), 1993-2002
Drug Discovery Contract Research Markets: Genzyme Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Johnson & Johnson Alliance Segment-wise Payouts (Global), 1985-2002
Drug Discovery Contract Research Markets: Johnson & Johnson Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Schering-Plough Alliance Segments (Global), 1990-2002
Drug Discovery Contract Research Markets: Schering-Plough Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Segment-wise Payouts (Global), 1986-2002
Drug Discovery Contract Research Markets: Pfizer (Excluding Pharmacia) Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Kirin Breweries Alliance Segment-wise Payouts (Global), 1995-2002
Drug Discovery Contract Research Markets: Kirin Breweries Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Gene Therapy Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Gene Therapy Alliance Revenues (Global), 1997-2002
Drug Discovery Contract Research Markets: Aventis Alliance Segment-wise Payouts (Global), 1991-2002
Drug Discovery Contract Research Markets: Aventis Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Japan Tobacco Alliance Segment-wise Payouts (Global), 1991-2002
Drug Discovery Contract Research Markets: Japan Tobacco Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Schering AG Alliance Segment-wise Payouts (Global), 1993-2002
Drug Discovery Contract Research Markets: Schering AG Alliance Payouts (Global), 1998-2002
Drug Discovery Contract Research Markets: Celltech Alliance Segment-wise Payouts (Global), 1989-2002
Drug Discovery Contract Research Markets: Celltech Alliance Payouts (Global), 1998-2002

Chapter 4

Market Opportunity Analysis
Drug Discovery Contract Research Markets: Segment-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Broad-based Screening Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Oncology Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Genomic Targets Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Chemistry Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Infection Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Autoimmune/Inflammation Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Gene Therapy Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: CNS Segment-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Metabolic Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: CVS Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Alliance Revenue by Segment (Global), 1997-March, 2003
Drug Discovery Contract Research Markets: Alliance Revenue Technology Platform (Global), 1997- March, 2003
Drug Discovery Contract Research Markets: Alliance Revenue Diseases (Global), 1997-March, 2003
Drug Discovery Contract Research Markets: Number of Alliances-Pharma (Global), 1973-2002
Drug Discovery Contract Research Markets: Number of Alliances - Biotech (Global), 1973-2002

Chapter 5

Sustainable Growth Strategies
Drug Discovery Contract Research Markets: Broad-based Screening Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Chemistry Category-wise Alliance Payouts (Global), 1997-2002
Drug Discovery Contract Research Markets: Alliance Revenue by Area (Global), 1997-March, 2003
Drug Discovery Contract Research Markets: Category-wise Alliance Payouts (Global), 1997-2002

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos